Stocky turns companies like COMPUGROUP MEDICAL SE COMPUGROU into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.
Try Stocky free →Cautious. 0MSD.L's Growth Compounder Score of 31.9 and Value Compounder Score of 28 suggest modest operational momentum without pricing power or durable competitive edges. Leadership Alignment at 52/100 reflects misalignment between management incentives and shareholder value creation. Vulnerability Profile shows adequate but not robust financial buffers—the company lacks structural moats to weather sector headwinds or competitive pressure.
Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for COMPUGROUP MEDICAL SE COMPUGROU:
Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 42/100, you know instantly whether to dig deeper or skip.
Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.
Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.
Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.
Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.
Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.
Stocky rates COMPUGROUP MEDICAL SE COMPUGROU (0MSD.L) at 42/100 — below the bar Stocky looks for. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Cautious. 0MSD.L's Growth Compounder Score of 31.9 and Value Compounder Score of 28 suggest modest operational momentum without pricing power or durable competitive edges. Leadership Alignment at 52/100 reflects misalignment between man
0MSD.L's current Stocky Verdict is 42/100, placing it in the "Cautious" band. This composite combines a 33/100 Compounder score, 52/100 Leadership, Moat rating, and analyst signal.
Stocky hasn't finalised a Moat Score for COMPUGROUP MEDICAL SE COMPUGROU yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.
COMPUGROUP MEDICAL SE COMPUGROU scores 52/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.
COMPUGROUP MEDICAL SE COMPUGROU's Vulnerability Profile scores 50/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to COMPUGROUP MEDICAL SE COMPUGROU.
Sign up free and unlock the full analysis on 0MSD.L — the same tools professional analysts use, personalised to your portfolio:
Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.
This page is just a preview. Open the live, interactive version for the full picture:
Or jump straight to the interactive dashboard for 0MSD.L in the app.
